MediWound (MDWD) Capital Leases (2019 - 2020)
MediWound (MDWD) posted quarterly Capital Leases of $1.9 million for Q1 2020, down 6.75% year-over-year from $2.0 million in Q2 2019, and down 5.03% quarter-over-quarter from $2.0 million in Q4 2019.
MediWound (MDWD) Capital Leases (2019 - 2020) Analysis & Trends
MediWound's Capital Leases history runs 2 years deep, the most recent figure standing at $1.9 million for Q1 2020.
- In Q1 2020, Capital Leases fell 6.75% year-over-year to $1.9 million; the TTM figure through Mar 2020 stood at $1.9 million (down 6.75% YoY), while the FY2019 annual figure was $2.0 million, changed N/A from the prior year.
- Capital Leases for Q1 2020 stood at $1.9 million, down from $2.0 million in the prior quarter.
- The five-year high for Capital Leases was $2.0 million in Q1 2019, with the low at $1.9 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.91 Mn |
| Dec 31, 2019 | 2.01 Mn |
| Jun 30, 2019 | 2.02 Mn |
| Mar 31, 2019 | 2.04 Mn |